Come grow with us in Phoenix!
GCP is excited to announce a new partnership with Reddy GI! https://lnkd.in/g_z8r9Ve
Skip to main content
Come grow with us in Phoenix!
GCP is excited to announce a new partnership with Reddy GI! https://lnkd.in/g_z8r9Ve
To view or add a comment, sign in
Vice President, Google Cloud | Board Member | Senior Technology Executive | AI | ML | Cybersecurity | Digital Transformation
#GoogleCloud is helping DaVita transform their dialysis clinics from a center-based model to a patient-based model by leveraging #AI and #Cloud - delivering better patient outcomes at a lower cost. David Maughan Alan Cullop Jay Richardson Aashima Gupta
To view or add a comment, sign in
If you want a great illustration of the unexpected ways cloud tech can transform individual businesses and entire industries, look no further than the experience of DaVita Kidney Care. With their Center Without Walls, they were able to totally reinvent how they connect patient data within the organization and with partner doctors and facilities across the world. This story is a testament to cloud's ability to help break down barriers and accelerate innovation. And above all, it is leading to more freedom for patients and better health outcomes.
To view or add a comment, sign in
CONCLUSIVE real-time remote patient Cardiac & Vitals diagnostics, with early detection, deterioration, diagnosis & adverse event prediction, patients treated sooner. Supporting the HSE, NHS & Private healthcare.
𝗜𝗺𝗽𝗹𝗮𝗻𝘁𝗮𝗯𝗹𝗲 𝗟𝗼𝗼𝗽 𝗿𝗲𝗰𝗼𝗿𝗱𝗶𝗻𝗴 𝗺𝗼𝗻𝗶𝘁𝗼𝗿𝘀. Lower the costs of your invasive implantable Loop monitors. Using a non invasive simple discrete SmartCardia patch, cardiology departments are reducing the use and costs of invasive implantable loop recorders. Many Implantable invasive Loop recorders detect most of the patients arrhythmias within the first two weeks, and patients are treated accordingly. However a Smartcardia 7-lead patch monitor can monitor for up to 30days, its non-invasive and produces highly conclusive, clean, clear, low noise ECG, on 7-leads of morphology. The Smartcardia Monitor is simple and fast to fit, it requires no lab time or invasive clinical procedures to fit or remove from patient. The Smartcardia monitor can be remotely monitored live in real-time wherever the patient is, so that arrhythmias are diagnosed faster. Smartcardia monitors do not require downloading from base stations or visits to hospitals for device reading. Common complications with Invasive implantable loop monitors, is a pain at the implant site. Risks of the procedure can include a local pocket infection that may require removal of the implanted device or a local skin reaction to the device. Poor R-wave sensing is a can be a complication that may require moving the device to another location. Smartcardia monitored patients, can be viewed by the clinicians from anywhere. The monitor can be set up to send alerts to clinicians to view and respond to live events in real-time, so patients get treated much sooner. 𝗦𝗺𝗮𝗿𝘁𝗖𝗮𝗿𝗱𝗶𝗮 𝗶𝘀 𝘁𝗵𝗲 𝘀𝗺𝗮𝗿𝘁 𝗰𝗵𝗼𝗶𝗰𝗲 𝗳𝗼𝗿 𝘁𝗵𝗲 𝗳𝗶𝗿𝘀𝘁 𝘀𝘁𝗲𝗽 𝗶𝗻 𝗱𝗶𝗮𝗴𝗻𝗼𝘀𝗶𝗻𝗴 𝗮 𝗽𝗮𝘁𝗶𝗲𝗻𝘁𝘀 𝗰𝗮𝗿𝗱𝗶𝗮𝗰 𝗮𝗿𝗿𝗵𝘆𝘁𝗵𝗺𝗶𝗮, 𝗳𝗮𝘀𝘁 𝗮𝗻𝗱 𝗰𝗼𝗻𝗰𝗹𝘂𝘀𝗶𝘃𝗲𝗹𝘆. Contact now and try a monitor: 𝒘𝒘𝒘.𝒔𝒎𝒂𝒓𝒕𝒄𝒂𝒓𝒅𝒊𝒂.𝒄𝒐𝒎 +44 (0) 7400028317
To view or add a comment, sign in
[NEW ON OUR BLOG] Our Head of Clinical Trials, Ashley Daigneau, explains how #RWD analytics are helping address the challenge of recruiting the right patients for the right trials. She also shares the new features added to our SaaS applications — VeraSite and Verana Trial Connect — that are expanding clinical trial opportunities: https://hubs.la/Q02CNjRC0
To view or add a comment, sign in
Dr Rowland Illing has some interesting reflections here on how Amazon Web Services (AWS) continues to advance basic services for model development in healthcare. Interested to see how the ecosystem develops. https://lnkd.in/e_VUvgg6
To view or add a comment, sign in
With the combined forces of Oracle and Cerner, Oracle Health is working to address patient recruitment, retention, and diversity challenges that occur throughout clinical trials. Learn how Oracle technologies can enhance clinical trial efficiency: https://lnkd.in/gGpdWrTn
To view or add a comment, sign in
https://lnkd.in/ev3-66YZ Epic Sepsis Model Reported is a 44% reduction in the odds of sepsis-related mortality after implementation of the ESM alert . Due to the wide utilization of Epic for EMRs and the ease of integration into the EMR, this is a promising tool for an immediate impact on the improvement of sepsis mortality throughout the United States.
To view or add a comment, sign in
𝐈𝐬 𝐢𝐭 𝐩𝐨𝐬𝐬𝐢𝐛𝐥𝐞 𝐭𝐨 𝐩𝐫𝐞𝐯𝐞𝐧𝐭 𝐇𝐀-𝐕𝐓𝐄 𝐢𝐧 𝐡𝐨𝐬𝐩𝐢𝐭𝐚𝐥𝐢𝐳𝐞𝐝 𝐜𝐡𝐢𝐥𝐝𝐫𝐞𝐧? 👶 The trial, published in JAMA Network Open, involved 17,427 pediatric hospitalizations, with patients randomized into control and intervention groups. It showed that despite the model's accuracy, the rate of 𝗛𝗔-𝗩𝗧𝗘 (𝘩𝘰𝘴𝘱𝘪𝘵𝘢𝘭-𝘢𝘤𝘲𝘶𝘪𝘳𝘦𝘥 𝘷𝘦𝘯𝘰𝘶𝘴 𝘵𝘩𝘳𝘰𝘮𝘣𝘰𝘦𝘮𝘣𝘰𝘭𝘪𝘴𝘮) didn't significantly differ between the two groups. 🧬 The researchers stressed the need to continue to develop 𝗻𝗲𝘄 𝘀𝘁𝗿𝗮𝘁𝗲𝗴𝗶𝗲𝘀 𝗮𝗻𝗱 𝗻𝗲𝘄 𝗽𝗿𝗲𝘃𝗲𝗻𝘁𝗶𝗼𝗻 𝗺𝗲𝗮𝘀𝘂𝗿𝗲𝘀, even with sophisticated prognostic tools. Read more in this article by Sara Scarpinati, Marketing Communications Manager at Healthware Group 👉 https://lnkd.in/d9dpGWz4 #AI #digitalhealth #innovation #HealthTech #HealthTransformation
To view or add a comment, sign in
Technical Leader | Radically Curious | Innovating Virtual Care with Computer Vision | Epic Certified | Clinical Workflow Nerd | Author | Happiest On, In or By the Water 🌊 🚣♀️ 🏄♀️
A Year of Journal Articles (Day 207/365) Zhang, Shan, Wei Cui, Shu Ding, Xiangyu Li, Xi-Wei Zhang, and Ying Wu. "A cluster-randomized controlled trial of a nurse-led artificial intelligence assisted prevention and management for delirium (AI-AntiDelirium) on delirium in intensive care unit: Study protocol." Plos one 19, no. 2 (2024): e0298793. Summary: Background: - Delirium is common in ICU patients and worsens their health outcomes. - Following the PADIS guidelines ("ABCDEF bundle") is important for preventing delirium, but adherence is low in practice. - AI-AntiDelirium, an AI-assisted tool, was developed to help nurses prevent and manage delirium. - A pilot study showed positive results for using AI-AntiDelirium in preventing delirium and improving patient outcomes. Methods: - A large-scale clinical trial will assess the impact of AI-AntiDelirium on ICU delirium. - Six ICUs in two hospitals will be randomly assigned to use AI-AntiDelirium or follow the PADIS guidelines. - Over 1450 patients aged 50+ will be included from each group. - The study will measure various outcomes, including: Incidence of ICU delirium Duration of delirium Length of ICU and hospital stay Mortality rates in ICU and hospital Patient cognitive function and daily living activities Nurse adherence to the ABCDEF bundle Discussion: - This trial aims to evaluate if AI-AntiDelirium effectively reduces delirium and improves outcomes while increasing adherence to guidelines. - If successful, it could significantly improve ICU delirium management in research and practice. I am interested to see the results of this one.
To view or add a comment, sign in
Check out this article published in Today's Clinical Lab, where Robert Scoggins, MD, PhD, Chief Medical Officer for Cytovale, shares his thoughts on 3 Ways Medical Lab Professionals Can Improve Sepsis Survival Rates.
To view or add a comment, sign in
1,056 followers